Deconstructing DTCA: Towards A Differentiated Policy Response To Direct-to-Consumer Advertising In Australia.
Funder
National Health and Medical Research Council
Funding Amount
$190,760.00
Summary
Spending on prescription pharmaceuticals is the fastest growing part of the health budget. In recent years attention has shifted to the impact of direct-to-consumer advertising (DTCA) on consumer demand and drug costs. Although DTCA is prohibited in Australia, it is clear that different types of DTCA are occurring. This study will examine the nature and range of DTCA, review the benefits and harms of DTCA, and identify the perspectives of major stakeholders regarding DTCA. The study will culmina ....Spending on prescription pharmaceuticals is the fastest growing part of the health budget. In recent years attention has shifted to the impact of direct-to-consumer advertising (DTCA) on consumer demand and drug costs. Although DTCA is prohibited in Australia, it is clear that different types of DTCA are occurring. This study will examine the nature and range of DTCA, review the benefits and harms of DTCA, and identify the perspectives of major stakeholders regarding DTCA. The study will culminate in a national workshop which will develop a differentiated set of recommendations for responding to different types and modes of DTCA. This is likely to lead to better health policy and to resources that may assist consumers and health professionals deal with DTCA.Read moreRead less
Effects Of Current And Plain Cigarette Package Design On Smokers Cigarette Evaluation
Funder
National Health and Medical Research Council
Funding Amount
$654,339.00
Summary
This project proposes to better understand the role of cigarette pack design on consumers' judgements that some cigarettes are safer than others. Three experimental studies are proposed, which will evaluate the influence of pack branding and colours, the potential impact of plain packaging, and the effect of larger size health warnings on consumer perceptions of cigarette health risks.
Investigation Of Tobacco Industry Efforts To Counteract Tobacco Control In Australia, 1970-2000
Funder
National Health and Medical Research Council
Funding Amount
$333,225.00
Summary
Tobacco use continues to be both the most important preventable cause of premature death and a key determinant of health inequity in Australia. Tobacco is a legally sold product which addicts many of its consumers, mostly as adolescents, and then kills half of them when used as intended. Comprehensive policy change, product regulation and litigation is required to put a halt to the tobacco industry's decades of avoidance, delay and disruption of tobacco control. In an interview for the Wall Stre ....Tobacco use continues to be both the most important preventable cause of premature death and a key determinant of health inequity in Australia. Tobacco is a legally sold product which addicts many of its consumers, mostly as adolescents, and then kills half of them when used as intended. Comprehensive policy change, product regulation and litigation is required to put a halt to the tobacco industry's decades of avoidance, delay and disruption of tobacco control. In an interview for the Wall Street Journal in 1995, Stan Glantz, from the University of California at San Francisco, equated the tobacco industry with other disease vectors: If you want to do something about malaria, you have to study mosquitoes and if you want to do something about lung cancer, you have to study the tobacco industry. Regulatory changes can only be justified by specific local evidence of both the private plans and knowledge of the tobacco industry to attack tobacco control and their public statements and actions designed to mislead consumers and effectively prevent or delay tobacco control. This study will document the public actions and statements of the tobacco industry in Australia between 1970 and 2000. It will draw on interviews with and personal records of tobacco control experts and former state and federal health ministers; as well as tobacco retail trade publications; print media reports; material obtained via Freedom of Information from State and Federal Health Departments; Federal Cabinet papers released under the 30 year rule (ie papers are available from prior 1972); and radio and television reports. It will complement a parallel study of the tobacco industry's internal documents. The outcome will be provision of strategically vital evidence to support effective tobacco control advocacy, policy formation, regulation and litigation in Australia, in the face of continuing industry countermeasures.Read moreRead less
Development And Evaluation Of A Decision Aid For Women With A Breech-presenting Baby.
Funder
National Health and Medical Research Council
Funding Amount
$156,890.00
Summary
Many studies have shown that women want to participate in clinical decisions about the treatments they receive during pregnancy and that involvement in decision making increases satisfaction with maternity care. Decision aids are interventions to help people make specific and deliberative decisions by providing information on the options and outcomes relevant to the person's health. This project aims to develop and evaluate the world's first decision aid for women with a breech presenting baby ( ....Many studies have shown that women want to participate in clinical decisions about the treatments they receive during pregnancy and that involvement in decision making increases satisfaction with maternity care. Decision aids are interventions to help people make specific and deliberative decisions by providing information on the options and outcomes relevant to the person's health. This project aims to develop and evaluate the world's first decision aid for women with a breech presenting baby (bottom rather than head first) in late pregnancy. A decision aid for breech presentation is timely because recent results of an international trial have dramatically altered women's options in the management of breech presentation. The trial of vaginal breech birth versus planned caesarean section (CS) found overwhelming evidence of reduced infant death and disability for women with a planned CS. Planned CS is now considered best practice for delivery of a breech presentation at birth. However, another treatment option for women with a breech presentation is turning the breech to head first before birth (called external cephalic version, ECV). Each of these options (ECV or planned CS) has benefits and risks, and the relative importance of these benefits and risks varies for individual women, a scenario where a decision aid produces the greatest benefit. The breech decision aid developed in this project will be based on the best and most recently available evidence and outcomes. It will incorporate a workbook, audiotape-CD and worksheet that will guide (but not direct) women to a treatment option that best suits them, taking ~20 minutes to complete. The decision aid will be evaluated to assess the impact on women's satisfaction with decision making, knowledge, anxiety and pregnancy outcomes. If successful, the results could be applied to improve consumer information and participation in clinical decisions across a wide spectrum of pregnancy care issues.Read moreRead less
An Ethical Analysis Of The Disclosure Of Surgeons' Performance Data To Patients Within The Informed Consent Process
Funder
National Health and Medical Research Council
Funding Amount
$148,937.00
Summary
For over a decade, hospitals in the American state of New York have been collecting information about the mortality rates of surgeons conducting Coronary Artery Bypass Grafts, and making this information available to patients. The United Kingdom is set to make these and other performance indicators on the ability of surgeons ('report cards') available from 2004. There are good reasons to think a similar system may be introduced in Australia in the near future. Patients can use the information co ....For over a decade, hospitals in the American state of New York have been collecting information about the mortality rates of surgeons conducting Coronary Artery Bypass Grafts, and making this information available to patients. The United Kingdom is set to make these and other performance indicators on the ability of surgeons ('report cards') available from 2004. There are good reasons to think a similar system may be introduced in Australia in the near future. Patients can use the information contained in report cards when deciding whether or not to consent to have a particular surgeon conduct an operation on them. Contemporary bioethicists stress the importance of a proper informed consent process in medicine. This is a process in which a doctor advises a patient of relevant information and ensures that the patient comprehends that information, before the patient consents to an operation. Currently report cards in America are publicly disseminated on the internet, however there is no systematic attempt to incorporate the information contained in report cards into the informed consent process. We do not know if patients understand the information they are given, or if they incorporate it into their decision making procedures appropriately. In our study we will consider how information that is contained in report cards could best be used in the informed consent process. We will keep in mind the importance of helping patients to make their own informed decisions to consent to operations, the importance of respecting the professional integrity of surgeons and the importance of providing the best possible standard of care for patients. The result of our study will be a revised model of the informed consent process that incorporates report cards in an ethically acceptable way.Read moreRead less
What Do Australians Think About Privacy And Participation In Epidemiological Research?
Funder
National Health and Medical Research Council
Funding Amount
$443,015.00
Summary
There is very little research available, in Australia or internationally, about what the general public considers privacy to be; or how important privacy protection is in the context of high and low risk epidemiological studies. We also know little about what affects willingness to participate in epidemiological research. Our research will provide an evidence base, and develop resources for the legislature, the NHMRC, ethics committees and researchers.